// App-Quantinova.ai

14033 : Differential Prognostic Implications of Peak Troponin Level in Acute Coronary Syndrome Treated With and Without Revascularization

Researchers

Presenter

  • Zhen Huang

Principal Investigators

  • Yuliya Lokhnygina

  • Pierluigi Tricoci

  • Kenneth W Mahaffey

  • Robert A Harrington

  • Paul W Armstrong

  • John Strony

  • Edmond Chen

  • Harvey D White

  • Claes Held

  • Frans Van de Werf

  • Lars Wallentin

Medical Centers

  • Duke Univ Medical Ctr/Duke Clinical Res Inst, Durham, NC

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden

  • Green Lane Cardiovascular Service, Auckland, New Zealand

  • Univ Hosps Leuven, Leuven, Belgium

Locations

  • Canada

  • Sweden

  • United States

  • Belgium

  • New Zealand

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Multi-vessel disease

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved